CLINICAL_TRIALS
trial_result
· 2022-05-18
Clinical Trial Update: Intestinal Permeability and Intestinal Microbiota in Irritable Bowel Syndrome [Phase 4]
Summary
Phase 4 clinical trial update examining intestinal permeability and microbiota in Irritable Bowel Syndrome with Diarrhea.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: I.M. Sechenov First Moscow State Medical University | Conditions: Irritable Bowel Syndrome With Diarrhea | Phase 4 | Status: UNKNOWN